Rare Cancers Australia and Canteen have launched their follow up report on rare cancers, Counting the cost: How we can assess the true value of investing in cancer treatment.
This follow-up report builds upon the initial report, which concentrated on determining the crucial factors to consider when investing in cancer treatment and offers a practical case study illustrating the effective integration of social value into health technology assessments.